SCHEMBL7815416

SCHEMBL7815416

O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCBr

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 6/20 0.51
ADRA1A P35348 6/20 0.51
ADRA1B P35368 5/20 0.51
DRD2 P14416 6/20 0.48
HTR1A P08908 5/20 0.48
HTR2A P28223 5/20 0.48
HTR7 P34969 5/20 0.48
HTR6 P50406 5/20 0.48
DRD4 P21917 1/20 0.48
DRD5 P21918 1/20 0.48
DRD3 P35462 1/20 0.48
CA9 Q16790 5/20 0.48
CA12 O43570 4/20 0.48
CA1 P00915 2/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
PAX8 Q06710 1/20 0.43
KLF5 Q13887 1/20 0.43
CA2 P00918 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8667679 0.89 DRD2 (0.48) DRD2HTR1AHTR2AHTR7HTR6
SCHEMBL8047953 0.85 ADRA1D (0.40) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL8667643 0.83 CA9 (0.51) ADRA1DADRA1AADRA1BDRD2DRD4
SCHEMBL8667503 0.83 ADRA1D (0.51) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL8670252 0.80 ADRA1D (0.53) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL8047935 0.80 ADRA1D (0.52) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL6324557 0.80 CA9 (0.73) ADRA1DADRA1AADRA1BDRD2HTR1A
SCHEMBL9480365 0.80 GAA (0.47) DRD2HTR1AHTR2AHTR7HTR6
SCHEMBL8671286 0.79 HDAC1 (0.55) ADRA1DADRA1AADRA1BCA9CA12
SCHEMBL9400876 0.79 ADRA1D (0.49) ADRA1DADRA1AADRA1BDRD2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0633260-B1 2,3-Dihydro-1,4-benzodioxan-5-yl-piperazine derivatives having 5-HT1A-antagonistic activity DUPHAR INT RES (NL) 2001-11-07 EP disclosed
US-6096763-A ADMINISTERING TO THE PATIENTS A2-OXO-1-BENZIMIDAZOLINYL)PIPERIDIN-1-YL)ALKYL)-1,2BENZISOTHIA ZOL-3-(2H)-ONE DERIVATIVE AS ALPHA-1A ADRENERGIC RECEPTOR ANTAGONIST MERCK & CO., INC. (US) 2000-08-01 US disclosed
US-5952351-A DERIVATIVES OF 1,1,3-TRIOXO-2-((2-OXOBENZIMIDAZOLIN- OR BENZOXAZOLIN-2-YL)-PIPERIDIN-4,1-YLENE-)-1,2-BENZISOTHIAZOLE; TREATMENT OF BENIGN PROSTATIC HYPERPLASIA; SELECTIVE RELAXATION OF SMOOTH MUSCLE WITHOUT INDUCING HYPOTENSION MERCK & CO., INC. (US) 1999-09-14 US disclosed
US-5807856-A Alpha 1a adrenergic receptor antagonist MERCK & CO., INC. (US) 1998-09-15 US disclosed
US-5760054-A BENIGN PROSTATIC HYPERTROPHY MERCK & CO., INC. (US) 1998-06-02 US disclosed
EP-0755392-A4 ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1997-05-02 EP disclosed
EP-0755392-A1 ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO. INC. (US) 1997-01-29 EP disclosed
WO-1996025934-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-08-29 WO disclosed
US-5462942-A 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT 1A-antagonistic activity DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1995-10-31 US disclosed
WO-1995028397-A1 ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1995-10-26 WO disclosed
EP-0633260-A1 2,3-Dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT1A-antagonistic activity DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1995-01-11 EP disclosed
US-5314884-A Antidepressants, anxiolytic agents TROPONWERKE GMBH & CO. (DE) 1994-05-24 US disclosed
US-5187276-A Anxiolytics, neuroleptics, antidepressants, and nootropic agents TROPONWERKE GMBH & CO. KG. (DE) 1993-02-16 US disclosed
US-4988809-A CENTRAL NERVOUS SYSTEM TROPONWERKE GMBH & CO., KG (DE) 1991-01-29 US disclosed
US-4937343-A NEUROLEPTICS OR ANTIDEPRESSANTS TROPONWERKE GMBH & CO. KG (DE) 1990-06-26 US disclosed
US-4818756-A CENTRAL NERVOUS SYSTEM DISORDERS TROPONWERKE GMBH & CO., KG (DE) 1989-04-04 US disclosed